13F

GH GUARDANT HEALTH INC

2026Q1 · CUSIP 40131M109 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
483
Δ holders QoQ
-13
Breadth percentile
Top 89%
Whale holders
207
Δ whales
-3
Inst. holding value
$12.5B
New positions
73
Closed positions
86
Price momentum (1Q)
-10.7%
Put / Call
12/10

Breadth history (34 quarters)

2019Q1: Δ+62 · h=151 2019Q2: Δ+68 · h=219 2019Q3: Δ+21 · h=240 2019Q4: Δ+25 · h=265 2020Q1: Δ+22 · h=287 2020Q2: Δ+35 · h=322 2020Q3: Δ+22 · h=344 2020Q4: Δ+71 · h=415 2021Q1: Δ-1 · h=414 2021Q2: Δ-2 · h=412 2021Q3: Δ-40 · h=372 2021Q4: Δ+22 · h=394 2022Q1: Δ-38 · h=356 2022Q2: Δ-27 · h=329 2022Q3: Δ-1 · h=328 2022Q4: Δ-34 · h=294 2023Q1: Δ-16 · h=278 2023Q2: Δ+20 · h=298 2023Q3: Δ-3 · h=295 2023Q4: Δ+0 · h=295 2024Q1: Δ-39 · h=256 2024Q2: Δ+27 · h=283 2024Q3: Δ-12 · h=271 2024Q4: Δ+28 · h=299 2025Q1: Δ+42 · h=341 2025Q2: Δ+24 · h=365 2025Q3: Δ+29 · h=394 2025Q4: Δ+102 · h=496 2026Q1: Δ-13 · h=483 2019Q1: holders=151 2019Q2: holders=219 2019Q3: holders=240 2019Q4: holders=265 2020Q1: holders=287 2020Q2: holders=322 2020Q3: holders=344 2020Q4: holders=415 2021Q1: holders=414 2021Q2: holders=412 2021Q3: holders=372 2021Q4: holders=394 2022Q1: holders=356 2022Q2: holders=329 2022Q3: holders=328 2022Q4: holders=294 2023Q1: holders=278 2023Q2: holders=298 2023Q3: holders=295 2023Q4: holders=295 2024Q1: holders=256 2024Q2: holders=283 2024Q3: holders=271 2024Q4: holders=299 2025Q1: holders=341 2025Q2: holders=365 2025Q3: holders=394 2025Q4: holders=496 2026Q1: holders=483 -102 -51 +0 +51 +102 135328521 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 15 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 3% -10.7%
2025Q3 Top 10% +10.3% +19.2%
2025Q2 Top 13% +58.7% +80.6%
2025Q1 Top 4% +45.6% +139.8%
2024Q4 Top 19% -16.6% +21.3%
2024Q2 Top 8% +8.1% +75.3%
2023Q2 Top 10% -30.3% -37.1%
2020Q4 Top 7% -35.0% -42.9%

Options Sentiment

Put holders
12
QoQ: -1
Call holders
10
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-3.40
EPS YoY
Revenue (TTM)
$1.1B
Revenue YoY
+39.6%
Quarterly Revenue & EPS (4Y)
2022-06-30: $109M 2022-09-30: $117M 2022-12-31: $127M 2023-03-31: $129M 2023-06-30: $137M 2023-09-30: $143M 2023-12-31: $155M 2024-03-31: $168M 2024-06-30: $177M 2024-09-30: $191M 2024-12-31: $202M 2025-03-31: $203M 2025-06-30: $232M 2025-09-30: $265M 2025-12-31: $281M 2026-03-31: $302M 2022-06-30: EPS -2.25 2022-09-30: EPS -1.58 2022-12-31: EPS -1.37 2023-03-31: EPS -1.30 2023-06-30: EPS -0.67 2023-09-30: EPS -0.73 2023-12-31: EPS -1.58 2024-03-31: EPS -0.94 2024-06-30: EPS -0.84 2024-09-30: EPS -0.88 2024-12-31: EPS -0.90 2025-03-31: EPS -0.77 2025-06-30: EPS -0.80 2025-09-30: EPS -0.74 2025-12-31: EPS -1.01 2026-03-31: EPS -0.85 0M 151M 302M $M -2.47 -1.24 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)